FDA Inspection
Paragon SwissParagon Swiss – FDA Inspection, Jan 12, 2024
Record Details
This FDA Inspection record concerns Paragon Swiss, with an inspection on January 12, 2024, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · e7d59826-eb1c-41a3-aa9a-043493e3ed3d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227806
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paragon Swiss
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2026 | Not classified | San Francisco District Office |
Other documents for Paragon Swiss
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.